Irinotecan monotherapy as third- or further-line treatment for patients with small cell lung cancer.
Tumori. 2021 Dec;107(6):536-541. doi: 10.1177/0300891620974762. Epub 2020 Nov 25.
Tumori. 2021.
PMID: 34847814